IMN || FDA & CDC

FDA approves palbociclib with letrozole for advanced postmenopausal breast cancer

Posted on: 03/02/2015 - 23:53

Palbociclib, a cyclin-dependent kinase 4/6 inhibitor, has been approved by the Food and Drug Administration for treating postmenopausal women with est... More »

Field of Interest: Pulmonology

Type: News Item

FDA approves palbociclib with letrozole for advanced postmenopausal breast cancer

Posted on: 03/02/2015 - 23:53

Palbociclib, a cyclin-dependent kinase 4/6 inhibitor, has been approved by the Food and Drug Administration for treating postmenopausal women with est... More »

Field of Interest: Oncology

Type: News Item

Improved version of gastric stimulator for gastroparesis approved as humanitarian device

Posted on: 03/02/2015 - 21:21

An improved version of a neurostimulator device for treating gastroparesis has been approved by the Food and Drug Administration, according to the man... More »

Field of Interest: Gastroentero...

Type: News Item

ACIP recommends pneumococcal vaccine for 65+ in 2015 schedule

Posted on: 02/02/2015 - 22:00

The 2015 adult immunization schedule is similar to last year’s schedule, with one major change, according to the Centers for Disease Control and Pre... More »

Field of Interest: Geriatrics

Type: News Item

FDA approves first generic version of Nexium

Posted on: 27/01/2015 - 00:35

The Food and Drug Administration approved the first generic formulation of esomeprazole magnesium delayed-release capsules, the agency announced Jan. ... More »

Field of Interest: Gastroentero...

Type: News Item

Updated HIV, HCV, HBV blood product screening test approved

Posted on: 24/01/2015 - 17:16

An updated version of a blood screening assay that detects human immunodeficiency virus type 1 (HIV-1), hepatitis C virus (HCV), and hepatitis B virus... More »

Field of Interest: Gastroentero...

Type: News Item

Secukinumab earns FDA approval for plaque psoriasis

Posted on: 21/01/2015 - 21:38

The U.S. Food and Drug Administration has approved secukinumab for the treatment of moderate to severe plaque psoriasis in adults. The injectable interleukin-17A inhibitor is indicated for...

Field of Interest: Dermatology

Type: News Item

FDA panel votes against approval of oral desmopressin for nocturia

Posted on: 13/01/2015 - 21:09

HYATTSVILLE, MD. – The majority of a Food and Drug Administration advisory panel voted against approval of an orally disintegrating sublingual table... More »

Field of Interest: Pulmonology

Type: News Item

FDA approves topical ivermectin for rosacea

Posted on: 23/12/2014 - 19:36

The Food and Drug Administration has approved a topical formulation of ivermectin for the once-daily topical treatment of inflammatory lesions related to rosacea. The drug will be marketed as...

Field of Interest: Dermatology

Type: News Item

FDA approves four-drug combination for HCV

Posted on: 19/12/2014 - 21:51

The Food and Drug Administration has approved the four-drug combination package Viekira Pak for the treatment of hepatitis C virus genotype 1 infection with or without cirrhosis, the agency announced...

Field of Interest: Gastroentero...

Type: News Item

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters